To clarify the molecular features of gastric cancer with negative ARID1A expression, we investigated the prognostic value of ARID1A and the relationship between ARID1A and cancer-related molecules, such as p53, MMR status (deficient MMR (dMMR) or proficient MMR (pMMR)), and PD-L1. The gene discussed is TP53; the disease is gastric cancer.